Paper22017641
Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin.
Ngo DA and 7 others. Br J Haematol, 2012. Cited by 106 papers, by iCite.
Cite this record
ConductScience Library. Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin. Papers, record 22017641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22017641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anemia, Sickle Cell | Major topic |
| Fetal Hemoglobin | Major topic |
| Hemoglobin, Sickle | Major topic |
| Adolescent | |
| Adult | |
| Child | |
| Child, Preschool | |
| Female | |
| Heterozygote | |
| Humans | |
| Infant | |
| Male | |
| Pregnancy | |
| Sequence Deletion | |
| Young Adult |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U54 HL070819 | NHLBI NIH HHS | United States | U54HL070819 | PubMed and NIH | NIH RePORTER |
| U54HL 70819 | NHLBI NIH HHS | United States | U54HL070819 | PubMed and NIH | NIH RePORTER |
| U54 HL070819-07 | NHLBI NIH HHS | United States | U54HL070819 | PubMed and NIH | NIH RePORTER |
| R01 DK069646 | NIDDK NIH HHS | United States | R01DK069646 | PubMed and NIH | NIH RePORTER |
| R01 DK088988 | NIDDK NIH HHS | United States | R01DK088988 | PubMed | NIH RePORTER |
| U01 HL133996 | NHLBI NIH HHS | United States | U01HL133996 | PubMed | NIH RePORTER |
| R01 HL068970 | NHLBI NIH HHS | United States | R01HL068970 | PubMed and NIH | NIH RePORTER |
| R01 HL098239 | NHLBI NIH HHS | United States | R01HL098239 | PubMed | NIH RePORTER |
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04586985 | Safety, Tolerability and Pharmacokinetics of FTX-6058 | Background | ClinicalTrials.gov | |
| NCT05169580 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir | Background | ClinicalTrials.gov |
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2445400 | The deletion in both common types of hereditary persistence of fetal hemoglobin is approximately 105 kilobases. | Blood | 1987 | https://conductscience.org/library/papers/2445400 | PubMed |
| 2 | 7685112 | Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/7685112 | PubMed |
| 3 | 1716963 | Two different forms of homozygous sickle cell disease occur in Saudi Arabia. | Br J Haematol | 1991 | https://conductscience.org/library/papers/1716963 | PubMed |
| 4 | 14022587 | Hereditary persistence of fetal hemoglobin: a study of 79 affected persons in 15 Negro families in Baltimore. | Blood | 1963 | https://conductscience.org/library/papers/14022587 | PubMed |
| 5 | 9668525 | Molecular basis of hereditary persistence of fetal hemoglobin. | Ann N Y Acad Sci | 1998 | https://conductscience.org/library/papers/9668525 | PubMed |
| 6 | 21490337 | Fetal hemoglobin in sickle cell anemia. | Blood | 2011 | https://conductscience.org/library/papers/21490337 | PubMed |
| 7 | 7532353 | Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. | Am J Hematol | 1995 | https://conductscience.org/library/papers/7532353 | PubMed |
| 8 | 7715639 | Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. | N Engl J Med | 1995 | https://conductscience.org/library/papers/7715639 | PubMed |
| 9 | 7679078 | Hb F in sickle cell anemia. | Experientia | 1993 | https://conductscience.org/library/papers/7679078 | PubMed |
| 10 | 6201160 | Heterogeneity in the molecular basis of three types of hereditary persistence of fetal hemoglobin and the relative synthesis of the G gamma and A gamma types of gamma chain. | Biochem Genet | 1984 | https://conductscience.org/library/papers/6201160 | PubMed |
| 11 | 804182 | Fetal hemoglobin restriction to a few erythrocytes (F cells) in normal human adults. | Science | 1975 | https://conductscience.org/library/papers/804182 | PubMed |
| 12 | 1100141 | F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F. | Blood | 1975 | https://conductscience.org/library/papers/1100141 | PubMed |
| 13 | 8980259 | Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease. | Am J Hematol | 1997 | https://conductscience.org/library/papers/8980259 | PubMed |
| 14 | 2421710 | Differences between the levels of G gamma chain in the fetal hemoglobin in two types of hereditary persistence of fetal hemoglobin are linked with a variation in the DNA sequence. | Biochem Genet | 1986 | https://conductscience.org/library/papers/2421710 | PubMed |
| 15 | 17541294 | Hemoglobin F concentration as a function of age in Kuwaiti sickle cell disease patients. | Med Princ Pract | 2007 | https://conductscience.org/library/papers/17541294 | PubMed |
| 16 | 5260159 | Hereditary persistence of fetal hemoglobin. | Ann N Y Acad Sci | 1969 | https://conductscience.org/library/papers/5260159 | PubMed |
Cited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42708011 | Uganda's Mandatory Newborn Sickle Cell Disease Screening Programme: Translating a Decade of Evidence into Differentiated Implementation. | Pediatric Health Med Ther | 2026 | https://conductscience.org/library/papers/42708011 | PubMed |
| 42448623 | A New Fetal Hemoglobin-Related Phenotype in Sickle Cell Anemia. | Am J Hematol | 2026 | https://conductscience.org/library/papers/42448623 | PubMed |
| 42239194 | Modeling Genetic Diversity in Sickle Cell Disease Reveals Heterogeneous Responses to HbF-Inducing Therapies. | bioRxiv | 2026 | https://conductscience.org/library/papers/42239194 | PubMed |
| 42040366 | Stroke From Paradoxical Embolism in a Young Patient With Sickle-Cell Disease and High Fetal Hemoglobin: A Diagnostic Challenge. | Clin Case Rep | 2026 | https://conductscience.org/library/papers/42040366 | PubMed |
| 42024469 | PGC-1α agonism via oral administration of ZLN005 induces fetal hemoglobin and is antisickling in sickle mice. | Blood Adv | 2026 | https://conductscience.org/library/papers/42024469 | PubMed |
| 41686455 | One cell at a time: HbF distribution in sickle cell disease. | Blood Adv | 2026 | https://conductscience.org/library/papers/41686455 | PubMed |
| 41351474 | Single-cell transcriptomics reveals heterocellular γ-globin gene expression in Aγδβ-thalassemia. | Blood Adv | 2026 | https://conductscience.org/library/papers/41351474 | PubMed |
| 41348017 | Optimizing the right time to start sickle cell therapies. | Hematology Am Soc Hematol Educ Program | 2025 | https://conductscience.org/library/papers/41348017 | PubMed |
| 41107978 | Comprehensive regulation of γ-globin expression by epigenetic modifications and protein post-translational modifications. | Clin Epigenetics | 2025 | https://conductscience.org/library/papers/41107978 | PubMed |
| 40966451 | Hematopoietic stem cell therapy with gene modification to treat sickle cell disease. | Stem Cells Transl Med | 2025 | https://conductscience.org/library/papers/40966451 | PubMed |
| 40332031 | Novel, potent, and orally bioavailable LSD1 inhibitors induce fetal hemoglobin synthesis in a sickle cell disease mouse model. | Blood | 2025 | https://conductscience.org/library/papers/40332031 | PubMed |
| 40124403 | Sticking together: Polymerization of sickle hemoglobin drives the multiscale pathophysiology of sickle cell disease. | Biophys Rev (Melville) | 2025 | https://conductscience.org/library/papers/40124403 | PubMed |
| 40084327 | Microcytosis Merits Evaluation: A Case Report of Hemoglobin S With Hereditary Persistence of Fetal Hemoglobin (HbS-HPFH Syndrome). | Cureus | 2025 | https://conductscience.org/library/papers/40084327 | PubMed |
| 40083162 | Current and future treatments for sickle cell disease: From hematopoietic stem cell transplantation to in vivo gene therapy. | Mol Ther | 2025 | https://conductscience.org/library/papers/40083162 | PubMed |
| 39595957 | Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39595957 | PubMed |
| 39549502 | Exploring Novel Strategies to Alleviate Symptoms of β-Globinopathies: Examining the Potential Role of Embryonic ε-globin Induction. | Transfus Med Rev | 2024 | https://conductscience.org/library/papers/39549502 | PubMed |
| 39448799 | BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations. | Eur J Hum Genet | 2025 | https://conductscience.org/library/papers/39448799 | PubMed |
| 39371249 | Sickle Cell Disease. | Transfus Med Hemother | 2024 | https://conductscience.org/library/papers/39371249 | PubMed |
| 39271903 | Fostering a healthier generation of children with sickle cell disease through advancements in care. | Pediatr Res | 2025 | https://conductscience.org/library/papers/39271903 | PubMed |
| 39209956 | Identification of genetic variants associated with clinical features of sickle cell disease. | Sci Rep | 2024 | https://conductscience.org/library/papers/39209956 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HBB | 3043 | PubTator's text mining | https://conductscience.org/library/genes/3043 | NCBI Gene |
| HBD | 100187828 | PubTator's text mining | https://conductscience.org/library/genes/100187828 | NCBI Gene |
| HBFQTL2 | 7954 | PubTator's text mining | https://conductscience.org/library/genes/7954 | NCBI Gene |
| HBG1 | 3047 | PubTator's text mining | https://conductscience.org/library/genes/3047 | NCBI Gene |
| HBG2 | 3048 | PubTator's text mining | https://conductscience.org/library/genes/3048 | NCBI Gene |
| HPFH2 | 3247 | PubTator's text mining | https://conductscience.org/library/genes/3247 | NCBI Gene |
| KRT90P | 85340 | PubTator's text mining | https://conductscience.org/library/genes/85340 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22017641
GET https://conductscience.org/api/papers/v1/22017641/cited_by?page=2